3.5.0.2 html 159 259 1 false 53 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Disclosure - Nature of the Business Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNatureOfBusiness Nature of the Business Notes 6 false false R7.htm 100060 - Disclosure - Basis of Presentation and Consolidation Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBasisOfPresentationAndConsolidation Basis of Presentation and Consolidation Notes 7 false false R8.htm 100070 - Disclosure - Net Loss Per Common Share Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNetLossPerCommonShare Net Loss Per Common Share Notes 8 false false R9.htm 100080 - Disclosure - License and Collaboration Agreements Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureLicenseAndCollaborationAgreements License and Collaboration Agreements Notes 9 false false R10.htm 100090 - Disclosure - Product Revenue Reserves and Allowances Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureProductRevenueReservesAndAllowances Product Revenue Reserves and Allowances Notes 10 false false R11.htm 100100 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 11 false false R12.htm 100110 - Disclosure - Marketable Securities Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 12 false false R13.htm 100120 - Disclosure - Inventory Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureInventory Inventory Notes 13 false false R14.htm 100130 - Disclosure - Accounts Payable, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other Notes 14 false false R15.htm 100140 - Disclosure - Borrowings Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowings Borrowings Notes 15 false false R16.htm 100150 - Disclosure - Restructuring Activities Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRestructuringActivities Restructuring Activities Notes 16 false false R17.htm 100160 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 100170 - Disclosure - Recent Accounting Pronouncements Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRecentAccountingPronouncements Recent Accounting Pronouncements Notes 18 false false R19.htm 100180 - Disclosure - Subsequent Event Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureSubsequentEvent Subsequent Event Notes 19 false false R20.htm 100190 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRecentAccountingPronouncements 20 false false R21.htm 100200 - Disclosure - Basis of Presentation and Consolidation (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationTables Basis of Presentation and Consolidation (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBasisOfPresentationAndConsolidation 21 false false R22.htm 100210 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNetLossPerCommonShareTables Net Loss Per Common Share (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNetLossPerCommonShare 22 false false R23.htm 100220 - Disclosure - License and Collaboration Agreements (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsTables License and Collaboration Agreements (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureLicenseAndCollaborationAgreements 23 false false R24.htm 100230 - Disclosure - Product Revenue Reserves and Allowances (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureProductRevenueReservesAndAllowancesTables Product Revenue Reserves and Allowances (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureProductRevenueReservesAndAllowances 24 false false R25.htm 100240 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureFairValueOfFinancialInstruments 25 false false R26.htm 100250 - Disclosure - Marketable Securities (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureMarketableSecurities 26 false false R27.htm 100260 - Disclosure - Inventory (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureInventoryTables Inventory (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureInventory 27 false false R28.htm 100270 - Disclosure - Accounts Payable, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherTables Accounts Payable, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther 28 false false R29.htm 100280 - Disclosure - Borrowings (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowingsTables Borrowings (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowings 29 false false R30.htm 100290 - Disclosure - Restructuring Activities (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRestructuringActivitiesTables Restructuring Activities (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRestructuringActivities 30 false false R31.htm 100300 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensation 31 false false R32.htm 100310 - Disclosure - Basis of Presentation and Consolidation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationAdditionalInformationDetail Basis of Presentation and Consolidation - Additional Information (Detail) Details 32 false false R33.htm 100320 - Disclosure - Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationScheduleOfNonControllingInterestInSubsidiaryDetail Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Details 33 false false R34.htm 100330 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail Net Loss Per Common Share - Additional Information (Detail) Details 34 false false R35.htm 100340 - Disclosure - Net Loss Per Common Share - Schedule of Outstanding Securities Excluded from Computation of Diluted Loss Per Share (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfOutstandingSecuritiesExcludedFromComputationOfDilutedLossPerShareDetail Net Loss Per Common Share - Schedule of Outstanding Securities Excluded from Computation of Diluted Loss Per Share (Detail) Details 35 false false R36.htm 100350 - Disclosure - License and Collaboration Agreements - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformationDetail License and Collaboration Agreements - Additional Information (Detail) Details 36 false false R37.htm 100360 - Disclosure - License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsScheduleOfRevenueRecognizedAndAssetsAndLiabilitiesUnderCollaborativeArrangementsDetail License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Details 37 false false R38.htm 100370 - Disclosure - Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureProductRevenueReservesAndAllowancesSummaryOfProductRevenueReserveAndAllowanceCategoriesDetail Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Details 38 false false R39.htm 100380 - Disclosure - Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetail Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Details 39 false false R40.htm 100390 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetail Marketable Securities - Schedule of Marketable Securities (Detail) Details 41 false false R42.htm 100410 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 42 false false R43.htm 100420 - Disclosure - Inventory - Schedule of Inventory (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureInventoryScheduleOfInventoryDetail Inventory - Schedule of Inventory (Detail) Details 43 false false R44.htm 100430 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOtherDetail Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 44 false false R45.htm 100440 - Disclosure - Borrowings - 2022 Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowings2022NotesAdditionalInformationDetail Borrowings - 2022 Notes - Additional Information (Detail) Details 45 false false R46.htm 100450 - Disclosure - Borrowings - Convertible Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowingsConvertibleNotesAdditionalInformationDetail Borrowings - Convertible Notes - Additional Information (Detail) Details 46 false false R47.htm 100460 - Disclosure - Borrowings - Silver Creek Convertible Promissory Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowingsSilverCreekConvertiblePromissoryNotesAdditionalInformationDetail Borrowings - Silver Creek Convertible Promissory Notes - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureBorrowingsScheduleOfFutureMinimumPaymentsUnderLoansPayableDetail Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Details 48 false false R49.htm 100480 - Disclosure - Restructuring Activities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRestructuringActivitiesAdditionalInformationDetail Restructuring Activities - Additional Information (Detail) Details 49 false false R50.htm 100490 - Disclosure - Restructuring Activities - Summary of Charges Related to Restructuring Activities (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureRestructuringActivitiesSummaryOfChargesRelatedToRestructuringActivitiesDetail Restructuring Activities - Summary of Charges Related to Restructuring Activities (Detail) Details 50 false false R51.htm 100500 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 51 false false R52.htm 100510 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToCalculateFairValueOfOptionsGrantedToEmployeesDetail Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Details 52 false false R53.htm 100520 - Disclosure - Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRecognizedStockBasedCompensationExpenseDetail Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 53 false false R54.htm 100530 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 54 false false R55.htm 100540 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20160930/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail Subsequent Event - Additional Information (Detail) Details 55 false false All Reports Book All Reports mack-20160930.xml mack-20160930.xsd mack-20160930_cal.xml mack-20160930_def.xml mack-20160930_lab.xml mack-20160930_pre.xml true true